These are the sources and citations used to research FHS Project Write Up. This bibliography was generated on Cite This For Me on

  • Website



    In-text: ("Cancer")

    Your Bibliography: "Cancer." N.p., 2019. Web. 14 Sept. 2019.

  • Journal

    Diaz, L. K., Cryns, V. L., Symmans, W. F. and Sneige, N.

    Triple Negative Breast Carcinoma and the Basal Phenotype: From Expression Profiling to Clinical Practice

    2007 - Advances in Anatomic Pathology

    In-text: (Diaz et al. 419-430)

    Your Bibliography: Diaz, Leslie K. et al. "Triple Negative Breast Carcinoma And The Basal Phenotype: From Expression Profiling To Clinical Practice." Advances in Anatomic Pathology 14.6 (2007): 419-430. Web.

  • Journal

    Erb, M. A., Scott, T. G., Li, B. E., Xie, H., Paulk, J., Seo, H., Souza, A., Roberts, J. M., Dastjerdi, S., Buckley, D. L., Sanjana, N. E., Shalem, O., Nabet, B., Zeid, R., Offei-Addo, N. K., Dhe-Paganon, S., Zhang, F., Orkin, S. H., Winter, G. E. and Bradner, J. E.

    Transcription control by the ENL YEATS domain in acute leukaemia

    2017 - Nature

    In-text: (Erb et al. 270-274)

    Your Bibliography: Erb, Michael A. et al. "Transcription Control By The ENL YEATS Domain In Acute Leukaemia." Nature 543.7644 (2017): 270-274. Web.

  • Journal

    Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises

    2017 - Cancer Genomics & Proteomics

    In-text: ("Histone Deacetylases As New Therapeutic Targets In Triple-Negative Breast Cancer: Progress And Promises")

    Your Bibliography: "Histone Deacetylases As New Therapeutic Targets In Triple-Negative Breast Cancer: Progress And Promises." Cancer Genomics & Proteomics 14.5 (2017): n. pag. Web.

  • Journal

    Jerusalem, G., Collignon, J., Schroeder, H. and Lousberg, L.

    Triple-negative breast cancer: treatment challenges and solutions

    2016 - Breast Cancer: Targets and Therapy

    In-text: (Jerusalem et al. 93)

    Your Bibliography: Jerusalem, Guy et al. "Triple-Negative Breast Cancer: Treatment Challenges And Solutions." Breast Cancer: Targets and Therapy (2016): 93. Web.

  • Journal

    McCann, K. E. and Hurvitz, S. A.

    Advances in the use of PARP inhibitor therapy for breast cancer

    2018 - Drugs in Context

    In-text: (McCann and Hurvitz 1-30)

    Your Bibliography: McCann, Kelly E, and Sara A Hurvitz. "Advances In The Use Of PARP Inhibitor Therapy For Breast Cancer." Drugs in Context 7 (2018): 1-30. Web.

  • Journal

    Moustakim, M., Christott, T., Monteiro, O. P., Bennett, J., Giroud, C., Ward, J., Rogers, C. M., Smith, P., Panagakou, I., Díaz-Sáez, L., Felce, S. L., Gamble, V., Gileadi, C., Halidi, N., Heidenreich, D., Chaikuad, A., Knapp, S., Huber, K. V. M., Farnie, G., Heer, J., Manevski, N., Poda, G., Al-awar, R., Dixon, D. J., Brennan, P. E. and Fedorov, O.

    Discovery of an MLLT1/3 YEATS Domain Chemical Probe

    2018 - Angewandte Chemie International Edition

    In-text: (Moustakim et al. 16302-16307)

    Your Bibliography: Moustakim, Moses et al. "Discovery Of An MLLT1/3 YEATS Domain Chemical Probe." Angewandte Chemie International Edition 57.50 (2018): 16302-16307. Web.

  • Journal

    Mueller, D., Bach, C., Zeisig, D., Garcia-Cuellar, M., Monroe, S., Sreekumar, A., Zhou, R., Nesvizhskii, A., Chinnaiyan, A., Hess, J. L. and Slany, R. K.

    A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification

    2007 - Blood

    In-text: (Mueller et al. 4445-4454)

    Your Bibliography: Mueller, D. et al. "A Role For The MLL Fusion Partner ENL In Transcriptional Elongation And Chromatin Modification." Blood 110.13 (2007): 4445-4454. Web.

  • Journal

    Perlman, E. J., Gadd, S., Arold, S. T., Radhakrishnan, A., Gerhard, D. S., Jennings, L., Huff, V., Guidry Auvil, J. M., Davidsen, T. M., Dome, J. S., Meerzaman, D., Hsu, C. H., Nguyen, C., Anderson, J., Ma, Y., Mungall, A. J., Moore, R. A., Marra, M. A., Mullighan, C. G., Ma, J., Wheeler, D. A., Hampton, O. A., Gastier-Foster, J. M., Ross, N. and Smith, M. A.

    MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours

    2015 - Nature Communications

    In-text: (Perlman et al.)

    Your Bibliography: Perlman, Elizabeth J. et al. "MLLT1 YEATS Domain Mutations In Clinically Distinctive Favourable Histology Wilms Tumours." Nature Communications 6.1 (2015): n. pag. Web.

  • Journal

    Yokoyama, A., Lin, M., Naresh, A., Kitabayashi, I. and Cleary, M. L.

    A Higher-Order Complex Containing AF4 and ENL Family Proteins with P-TEFb Facilitates Oncogenic and Physiologic MLL-Dependent Transcription

    2010 - Cancer Cell

    In-text: (Yokoyama et al. 198-212)

    Your Bibliography: Yokoyama, Akihiko et al. "A Higher-Order Complex Containing AF4 And ENL Family Proteins With P-Tefb Facilitates Oncogenic And Physiologic MLL-Dependent Transcription." Cancer Cell 17.2 (2010): 198-212. Web.

  • Journal

    Zhao, D., Li, Y., Xiong, X., Chen, Z. and Li, H.

    YEATS Domain—A Histone Acylation Reader in Health and Disease

    2017 - Journal of Molecular Biology

    In-text: (Zhao et al. 1994-2002)

    Your Bibliography: Zhao, Dan et al. "YEATS Domain—A Histone Acylation Reader In Health And Disease." Journal of Molecular Biology 429.13 (2017): 1994-2002. Web.

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Quick and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies